News
People suffering from arthritis will soon have a new over-the-counter treatment option. Voltaren Arthritis Pain, a non-steroidal anti-inflammatory topical gel, has been approved for over-the-counter ...
WARREN, N.J., May 3, 2021 /PRNewswire/ — GSK Consumer Healthcare (LSE/NYSE: GSK), the makers of Voltaren Arthritis Pain Gel (diclofenac sodium topical gel, 1%) today revealed new data that uncovers a ...
Your joints are often one of the first places you'll feel your age. Just getting out of bed each morning can produce a chorus of cracks and a symphony of soreness, and rather than reaching for a ...
Warren-based GlaxoSmithKline announced on Monday the U.S. Food and Drug Administration (FDA) approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1 percent arthritis pain reliever) as an ...
The FDA has approved Voltaren Arthritis Pain for nonprescription, over-the-counter use, according to a press release. Voltaren (diclofenac sodium topical gel 1%, GlaxoSmithKline), a NSAID previously ...
WARREN, N.J., Feb. 17, 2020 /PRNewswire/ -- GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results